Washington, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ASN Foundation for Kidney Research, founded in 2012, is a mid-sized nonprofit in the Medical Research sector that reported $14.2M in total revenue in fiscal year 2024. Revenue surged 396% from the prior year, signaling strong growth momentum. The organization ran a surplus of $11.1M, a strong 78% operating margin.
To prevent and cure kidney diseases through research and innovation.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $14,217,105 | $2,866,193 | +4.0% |
| Expenses | $3,074,681 | $2,836,650 | +0.1% |
| Net Income | $11,142,424 | $29,543 | +376.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Jeffrey S Berns MD FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Deidra C Crews MD MS FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Linda F Fried MD MPH FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Michelle A Jospehson MD FASN | Board Chair | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jeffrey H Miner PhD FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Patrick H Nachman MD FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Samir M Parikh MD FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Prabir Roy-Chaudhury MD PhD FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Daniel E Weiner MD MS FASN | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Tod Ibrahim | Executive Vice President | 1.00 |
Officer
|
$0 | $63,970 | $641,960 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $14,217,105 | $3,074,681 | $59,012,619 | $11,142,424 |
| 2023 | $2,866,193 | $2,836,650 | $55,918,343 | $29,543 |
| 2022 | $2,725,969 | $2,818,081 | $50,401,381 | $-92,112 |
| 2021 | $8,283,441 | $3,092,653 | $60,237,248 | $5,190,788 |
| 2020 | $1,641,647 | $2,801,155 | $55,530,641 | $-1,159,508 |
| 2019 | $3,218,086 | $2,698,772 | $51,341,553 | $519,314 |
| 2018 | $2,106,032 | $2,794,870 | $43,927,370 | $-688,838 |
Compare ASN Foundation for Kidney Research with other nonprofits in District of Columbia and across the country.